Karin contributes with management experience from the life science industry. She has a track record of leading listed companies and growing life science companies to an IPO.
Since 2015, Karin is the CEO of Invent Medic Sweden AB (listed on Spotlight Stock Market, Stockholm). She’s also co-founder and chairman of Colzyx AB and a board member of Wahlgrenska Stiftelsen.
Previous experience includes CEO at ProNoxis AB, Project Manager at Enzymatica AB and IPR Manager at Alligator.
Karin holds a PhD in Immunology from Lund University.
Holdings: No shares